Page last updated: 2024-09-04

perifosine and Leukemia, Myeloid, Acute

perifosine has been researched along with Leukemia, Myeloid, Acute in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (33.33)29.6817
2010's3 (50.00)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Aiche, S; Bassermann, F; Becker, W; Canevari, G; Casale, E; Depaolini, SR; Ehrlich, HC; Felder, ER; Feuchtinger, A; Garz, AK; Gohlke, BO; Götze, K; Greif, PA; Hahne, H; Heinzlmeir, S; Helm, D; Huenges, J; Jeremias, I; Kayser, G; Klaeger, S; Koch, H; Koenig, PA; Kramer, K; Kuster, B; Médard, G; Meng, C; Petzoldt, S; Polzer, H; Preissner, R; Qiao, H; Reinecke, M; Reiter, K; Rueckert, L; Ruland, J; Ruprecht, B; Schlegl, J; Schmidt, T; Schneider, S; Schoof, M; Spiekermann, K; Tõnisson, N; Vick, B; Vooder, T; Walch, A; Wilhelm, M; Wu, Z; Zecha, J; Zolg, DP1
Aloia, TPA; Amano, MT; Bizzarro, B; Gama, SM; Hernandes, C; Pereira, WO; Ribeiro, NM; Varela, VA1
Jin, Y; Liu, H; Meng, H; Qian, W; Yang, C; Yang, X; You, L1
Freeman, CL; Giles, FJ; Keane, N; Krawczyk, J; O'Dwyer, M; Swords, R1
Bontadini, A; Bortul, R; Chiarini, F; Cocco, L; Evangelisti, C; Martelli, AM; Martinelli, G; McCubrey, JA; Papa, V; Ricci, F; Tabellini, G; Tazzari, PL1
Billi, AM; Cappellini, A; Chiarini, F; Evangelisti, C; Martelli, AM; Martinelli, G; McCubrey, JA; Ottaviani, E; Papa, V; Ricci, F; Tazzari, PL; Testoni, N1

Reviews

1 review(s) available for perifosine and Leukemia, Myeloid, Acute

ArticleYear
Perifosine--a new option in treatment of acute myeloid leukemia?
    Expert opinion on investigational drugs, 2013, Volume: 22, Issue:10

    Topics: Antineoplastic Agents; Clinical Trials as Topic; Humans; Leukemia, Myeloid, Acute; Molecular Structure; Molecular Targeted Therapy; Phosphorylcholine; Proto-Oncogene Proteins c-akt; Signal Transduction; Treatment Outcome

2013

Other Studies

5 other study(ies) available for perifosine and Leukemia, Myeloid, Acute

ArticleYear
The target landscape of clinical kinase drugs.
    Science (New York, N.Y.), 2017, 12-01, Volume: 358, Issue:6367

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cytokines; Drug Discovery; fms-Like Tyrosine Kinase 3; Humans; Leukemia, Myeloid, Acute; Lung Neoplasms; Mice; Molecular Targeted Therapy; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Proteomics; Xenograft Model Antitumor Assays

2017
AKT inhibition interferes with the expression of immune checkpoint proteins and increases NK-induced killing of HL60-AML cells.
    Einstein (Sao Paulo, Brazil), 2023, Volume: 21

    Topics: Animals; HL-60 Cells; Humans; Immune Checkpoint Proteins; Leukemia, Myeloid, Acute; Mice; Mice, Nude; Proto-Oncogene Proteins c-akt

2023
SNS-032 inhibits mTORC1/mTORC2 activity in acute myeloid leukemia cells and has synergistic activity with perifosine against Akt.
    Journal of hematology & oncology, 2013, Feb-18, Volume: 6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Cell Proliferation; Drug Synergism; Enzyme-Linked Immunosorbent Assay; Female; Flow Cytometry; Humans; Leukemia, Myeloid, Acute; Male; Mechanistic Target of Rapamycin Complex 1; Mechanistic Target of Rapamycin Complex 2; Multiprotein Complexes; Oxazoles; Phosphorylation; Phosphorylcholine; Proto-Oncogene Proteins c-akt; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Thiazoles; TOR Serine-Threonine Kinases; Tumor Cells, Cultured

2013
Synergistic proapoptotic activity of recombinant TRAIL plus the Akt inhibitor Perifosine in acute myelogenous leukemia cells.
    Cancer research, 2008, Nov-15, Volume: 68, Issue:22

    Topics: Apoptosis; CASP8 and FADD-Like Apoptosis Regulating Protein; Caspase 8; Cell Survival; Drug Synergism; Hematopoietic Stem Cells; Humans; Leukemia, Myeloid, Acute; Mitogen-Activated Protein Kinase 9; Phosphorylcholine; Protein Kinase C; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-jun; Reactive Oxygen Species; Receptors, TNF-Related Apoptosis-Inducing Ligand; Recombinant Proteins; TNF-Related Apoptosis-Inducing Ligand; X-Linked Inhibitor of Apoptosis Protein

2008
Proapoptotic activity and chemosensitizing effect of the novel Akt inhibitor perifosine in acute myelogenous leukemia cells.
    Leukemia, 2008, Volume: 22, Issue:1

    Topics: Apoptosis; bcl-Associated Death Protein; Blotting, Western; Cell Proliferation; Colony-Forming Units Assay; Fas Ligand Protein; fas Receptor; Flow Cytometry; fms-Like Tyrosine Kinase 3; Humans; Immunoprecipitation; Leukemia, Myeloid, Acute; MAP Kinase Kinase 4; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Phosphatidylinositol 3-Kinases; Phosphorylation; Phosphorylcholine; Proto-Oncogene Proteins c-akt; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Tumor Cells, Cultured

2008